Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Magenkrebs-Risiko

Das Risiko eines Magenkarzinoms kann durch genetische Varianten im IL1RN-Gen, welches ein Interleukin 1 kodiert, vermittelt werden.

Gliederung

Erbliche Tumorerkrankungen
Hereditäre Hirntumoren
Hereditäre Nierentumoren
Hereditäre maligne Bluterkrankungen
Infantiles kapilläres Hämangiom
Karzinoidtumore der Lunge
Lipom
Lymphangioleiomyomatose
Magenkarzinom
Multiple selbsheilende palmoplantare Karzinome
Neigung zu Kaposi-Sarkomen
Neurofibromatose

Referenzen:

1.

Huntsman DG et al. (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

external link
2.

van der Post RS et. al. (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

external link
3.

Benusiglio PR et. al. (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.

external link
4.

Fitzgerald RC et. al. (2010) Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

external link
5.

Oliveira C et. al. (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families.

external link
6.

Frebourg T et. al. (2006) Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer.

external link
7.

Brooks-Wilson AR et. al. (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.

external link
8.

None (1965) THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

external link
9.

None (1964) FAMILIAL GASTRIC CANCER.

external link
10.

Oliveira C et. al. (2002) Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.

external link
11.

Chun YS et. al. (2001) Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?

external link
12.

None (1988) A human model of gastric carcinogenesis.

external link
13.

Lynch HT et. al. (2000) E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma.

external link
14.

Grady WM et. al. (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

external link
15.

Caldas C et al. (1999) Familial gastric cancer: overview and guidelines for management.

external link
16.

Guilford PJ et. al. (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.

external link
17.

Kakiuchi H et al. () Familial gastric cancer in the Japanese population is frequently located at the cardiac region.

external link
18.

Richards FM et. al. (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.

external link
19.

Gayther SA et. al. (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.

external link
20.

Guilford P et. al. (1998) E-cadherin germline mutations in familial gastric cancer.

external link
21.

Carneiro F et. al. (1995) New elements for an updated classification of the carcinomas of the stomach.

external link
Update: 13. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz